ArticleJournal of pharmaceutical analysis2022

Corrigendum to "The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review" [J. Pharma. Anal. 11 (2021) 265-271].

Leonny Dwi Rizkita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.